文献速递前列腺癌

转移性前列腺癌并发症患者的特征与结局

Characteristics and outcomes of men presenting with complications of metastatic prostate cancer.
PubMed 文献 · BJU Int · 2026-02-17

MRE风险随年龄、社会经济剥夺和居住地区变化,且MRE患者总生存较无MRE者更差。

要点

  • 8.9%的转移性前列腺癌患者以MRE就诊,其中57.4%为恶性输尿管梗阻(MUO)。
  • ≥80岁男性MRE风险最高(9.8%),贫困地区居民风险亦升高(aRR 1.27)。
  • 合并MUO和骨相关事件(SRE)者5年总死亡率达84.4%,预后最差。

核心结论

  • 转移性前列腺癌患者以MRE就诊的风险因年龄、社会经济剥夺和居住地区而异,且这些患者生存结局更差。

主要发现

  • 4272例(8.9%)以MRE就诊,其中MUO 2453例(57.4%)、SRE 1738例(40.7%)、两者兼有81例(1.9%)。
  • ≥80岁男性MRE风险最高(9.8% [1604/16452]),70-79岁(aRR 0.82, 95%CI 0.77-0.88)和60-69岁(aRR 0.91, 95%CI 0.84-0.98)风险较低。
  • 最贫困社区男性MRE风险高于最不贫困社区(9.3% [706/7609] vs 8.0% [868/10865];aRR 1.27, 95%CI 1.15-1.40)。
  • MRE就诊比例存在地区差异,范围为4.6%(288/6233)至11.7%(461/3951)。
  • 5年总死亡率:无MRE者57.8%(95%CI 57.2-58.4%),MUO者77.1%(95%CI 74.9-79.2%),SRE者66.8%(95%CI 64.1-69.4%),两者兼有者84.4%(95%CI 74.1-94.7%)。

临床怎么用

  • 临床应关注高龄、社会经济剥夺程度高及特定地区转移性前列腺癌患者的MRE风险,以便早期识别和干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe the incidence, characteristics and mortality of men who present with complications of metastatic prostate cancer, a previously under-reported population. We investigate men who present with and without malignant ureteric obstruction (MUO) and skeletal-related events (SREs), collectively termed 'metastatic-related events' (MREs). PATIENTS AND METHODS: We used the English Cancer Registry linked to hospital administrative data to identify men diagnosed with metastatic prostate cancer between January 2015 and December 2022. Poisson regression models estimated adjusted relative risks (aRRs) of presenting with MREs. The cumulative incidences of overall and prostate cancer-specific death were estimated for each MRE subgroup (metastatic without MRE, MUO, SRE, and MUO and SRE in combination). RESULTS: Of 48 171 men diagnosed with primary metastatic disease, 4272 (8.9%) presented with MREs. Of these men, 2453 (57.4%) had MUO, 1738 (40.7%) had a SRE, and 81 (1.9%) had both. Men aged ≥80 years had the highest risk (9.8% [1604/16452]) of presenting with MREs. Men aged 70-79 years (8.0% [1470/18397]) (aRR 0.82, 95% confidence interval [CI] 0.77-0.88) and men aged 60-69 years (8.9% [916/10297]) (aRR 0.91, 95%CI 0.84-0.98) had lower risks. Men from the most deprived neighbourhoods (9.3% [706/7609]) (aRR 1.27, 95% CI 1.15-1.40) had greater risks of presenting with MREs than those from the least deprived neighbourhoods (8.0% [868/10865]). The proportion of men presenting with MREs varied across geographical regions, ranging from 4.6% (288/6233) to 11.7% (461/3951). The 5-year overall mortality for men presenting without MREs was 57.8% (95% CI 57.2-58.4%), compared to 77.1% (95% CI 74.9-79.2%) with MUO, 66.8% (95% CI 64.1-69.4%) with a SRE and 84.4% (95% CI 74.1-94.7%) with both. CONCLUSIONS: The risk of presenting with metastatic prostate cancer and MREs varies according to age, socioeconomic deprivation, and residential region. These men have poorer survival outcomes than men diagnosed without MREs at diagnosis.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Nathan A, Parry MG, Cook A, et al. Characteristics and outcomes of men presenting with complications of metastatic prostate cancer. BJU Int. 2026. PMID: 41703717. doi:10.1111/bju.70179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。